Back to top
more

Medtronic (MDT)

(Delayed Data from NYSE)

$82.84 USD

82.84
4,217,829

+0.08 (0.10%)

Updated May 10, 2024 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (100 out of 251)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

Research for MDT

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

0 items in cart

Medtronic PLC [MDT]

Reports for Purchase

Showing records 461 - 480 ( 503 total )

Company: Medtronic PLC

Industry: Medical - Products

Record: 461

05/26/2011

Company Report

Pages: 11

Price: 24.95

Company: Medtronic PLC

Industry: Medical - Products

Record: 462

05/25/2011

Company Report

Pages: 2

Q4 Results show revenue growth remains challenging.

Provider: G.RESEARCH, LLC

Analyst: JONAS J

Price: 10.00

Research Provided by a Third Party

Company: Medtronic PLC

Industry: Medical - Products

Record: 463

05/24/2011

Company Report

Pages: 9

No End in Sight to Cardio, Spine Device Pressures - Revising FY 2012 Outlook

Provider: WEDBUSH SECURITIES INC.

Analyst: NALBONE P

Price: 25.00

Research Provided by a Third Party

Company: Medtronic PLC

Industry: Medical - Products

Record: 464

05/11/2011

Daily Note

Pages: 5

A Surprising Choice For CEO -- GE Healthcare Exec Brought In To Make Needed Changes -- Expect Those Changes To Come Slowly

Provider: WEDBUSH SECURITIES INC.

Analyst: NALBONE P

Price: 10.00

Research Provided by a Third Party

Company: Medtronic PLC

Industry: Medical - Products

Record: 465

04/18/2011

Daily Note

Pages: 19

March Quarter Preview

Provider: WEDBUSH SECURITIES INC.

Analyst: NALBONE P

Price: 50.00

Research Provided by a Third Party

Company: Medtronic PLC

Industry: Medical - Products

Record: 466

03/10/2011

Daily Note

Pages: 4

No Surprise In FDA''s "No" To Amplify

Provider: WEDBUSH SECURITIES INC.

Analyst: NALBONE P

Price: 10.00

Research Provided by a Third Party

Company: Medtronic PLC

Industry: Medical - Products

Record: 467

03/08/2011

Company Report

Pages: 11

Price: 24.95

Company: Medtronic PLC

Industry: Medical - Products

Record: 468

02/23/2011

Company Report

Pages: 2

Sluggish revenue growth continues

Provider: G.RESEARCH, LLC

Analyst: JONAS J

Price: 10.00

Research Provided by a Third Party

Company: Medtronic PLC

Industry: Medical - Products

Record: 469

02/22/2011

Company Report

Pages: 9

Q3 Results, Layoff Plans A Reflection Of Tough Times --See FY''12 Street Views As Too Optimistic

Provider: WEDBUSH SECURITIES INC.

Analyst: NALBONE P

Price: 25.00

Research Provided by a Third Party

Company: Medtronic PLC

Industry: Medical - Products

Record: 470

02/18/2011

Company Report

Pages: 9

Q3 Should Look Fine Relative to Modest Expectations - But FY''12 Consensus Views Look Too Optimistic

Provider: WEDBUSH SECURITIES INC.

Analyst: NALBONE P

Price: 25.00

Research Provided by a Third Party

Company: Medtronic PLC

Industry: Medical - Products

Record: 471

01/20/2011

Daily Note

Pages: 9

MORNING SUMMARY

Provider: RODMAN & RENSHAW, CO.

Price: 25.00

Research Provided by a Third Party

Company: Medtronic PLC

Industry: Medical - Products

Record: 472

01/19/2011

Daily Note

Pages: 3

Key changes to pivotal trial

Provider: RODMAN & RENSHAW, CO.

Analyst: KALIA S

Price: 10.00

Research Provided by a Third Party

Company: Medtronic PLC

Industry: Medical - Products

Record: 473

01/19/2011

Company Report

Pages: 4

Key changes to pivotal trial

Provider: RODMAN & RENSHAW, CO.

Analyst: KALIA S

Price: 10.00

Research Provided by a Third Party

Company: Medtronic PLC

Industry: Medical - Products

Record: 474

12/07/2010

Company Report

Pages: 13

Price: 24.95

Company: Medtronic PLC

Industry: Medical - Products

Record: 475

11/24/2010

Company Report

Pages: 3

UPDATING MODELS AFTER Q2-11 EARNINGS

Provider: RODMAN & RENSHAW, CO.

Price: 10.00

Research Provided by a Third Party

Company: Medtronic PLC

Industry: Medical - Products

Record: 476

11/23/2010

Company Report

Pages: 9

Q2 Results Squeak By,Management Again Trims FY Outlook-Growth Challenges Remain in Key Device Markets

Provider: WEDBUSH SECURITIES INC.

Analyst: NALBONE P

Price: 25.00

Research Provided by a Third Party

Company: Medtronic PLC

Industry: Medical - Products

Record: 477

11/17/2010

Company Report

Pages: 8

Investors Not Likely to Have Much to Be Thankful for Next Week - Expecting Another Weak Quarter and Another Round of Lowered Guidance

Provider: WEDBUSH SECURITIES INC.

Analyst: NALBONE P

Price: 25.00

Research Provided by a Third Party

Company: Medtronic PLC

Industry: Medical - Products

Record: 478

11/01/2010

Company Report

Pages: 13

Trimming Q2 Projections

Provider: WEDBUSH SECURITIES INC.

Analyst: NALBONE P

Price: 50.00

Research Provided by a Third Party

Company: Medtronic PLC

Industry: Medical - Products

Record: 479

10/18/2010

Daily Note

Pages: 29

Med Tech September Quarter Preview: Stagnation for Most Large Device Markets

Provider: WEDBUSH SECURITIES INC.

Analyst: NALBONE P

Price: 75.00

Research Provided by a Third Party

Company: Medtronic PLC

Industry: Medical - Products

Record: 480

09/20/2010

Company Report

Pages: 8

Reimbursement Pressures Loom for InFuse an Obstacle to Reviving the Franchise - but the Problem Is Still the Worsening of the Broader Spine and CRM Markets

Provider: WEDBUSH SECURITIES INC.

Analyst: NALBONE P

Price: 25.00

Research Provided by a Third Party